Virtual ligand screening against comparative protein structure models
- PMID: 22183533
- PMCID: PMC3386294
- DOI: 10.1007/978-1-61779-465-0_8
Virtual ligand screening against comparative protein structure models
Abstract
Virtual ligand screening uses computation to discover new ligands of a protein by screening one or more of its structural models against a database of potential ligands. Comparative protein structure modeling extends the applicability of virtual screening beyond the atomic structures determined by X-ray crystallography or NMR spectroscopy. Here, we describe an integrated modeling and docking protocol, combining comparative modeling by MODELLER and virtual ligand screening by DOCK.
Figures
References
-
- Kuntz ID. Structure-Based Strategies for Drug Design and Discovery. Science. 1992;257:1078–1082. - PubMed
-
- Klebe G. Recent developments in structure-based drug design. J Mol Med. 2000;78:269–281. - PubMed
-
- Ealick SE, Armstrong SR. Pharmacologically relevant proteins. Curr Opin Struct Biol. 1993;3:861–867.
-
- Gschwend DA, Good AC, Kuntz ID. Molecular docking towards drug discovery. J Mol Recognit. 1996;9:175–186. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
